A new scoring system might help physicians identify pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosis (PVOD/PCH), a rare but particularly dangerous subtype of pulmonary arterial hypertension (PAH), allowing for more appropriate treatment and earlier referral for lung transplantation.
Million Veterans Database Used in Large-Scale Analysis for Cardiometabolic Traits
Noting that studies linking mitochondrial DNA (mtDNA) with complex traits are often limited by small sample sizes or focused on specific phenotypes in clinically selected cohorts, researchers recently reported data from more than 600,000 participants in the Million Veteran Program (MVP) to perform a multiancestry analysis of mitochondrial DNA (mtDNA) variation and cardiometabolic phenotypes across European (EUR), African (AFR), Admixed American (AMR) and East Asian (EAS) populations.
VA Researchers Featured in Dozens of Presentations at ASCO 2026
Studies address DPYD pharmacogenomics, lung cancer eligibility criteria, advance care planning, prostate cancer genomics, fatigue treatment, and more.
Costs of Care, Oncologic Outcomes Related to Blue Light Cystoscopy at VA
Higher upfront costs vs. improved recurrence outcomes are a tradeoff when incorporating blue light cystoscopy (BLC) into nonmuscle-invasive bladder cancer (NMIBC) management, according to a new study.
Military Population Shows High Adherence to Stool DNA Colorectal Cancer Screening
Colorectal cancer screening rates remain below national targets in the general U.S. population, but a large new study suggested that adherence might be substantially higher among military members, retirees and their families.
About Half of Post-9/11 Veterans Found to Have High Blood Pressure, Often Undiagnosed, Untreated
High blood pressure, often undiagnosed and untreated, is widespread among post-9/11 U.S. veterans and is found at a much greater rate compared to the general public, according to a new study.
Pharmacogenomic Testing Could Reduce Adverse Effects, Therapeutic Failure in MHS
Pharmacogenomic testing is an underutilized resource in the Military Health System (MHS) that could reduce adverse drug events and therapeutic failure.
Eye Tests Revealed That Brain Trauma Can Persist in Veterans More Than a Decade After Concussion
Brain function differences can continue in veterans more than a decade after concussion, according to a new study which found the subtle deviations through specialized eye movement testing.
VA Clinicians Should Counsel Semaglutide Initiators About a 2-Fold Greater Risk of Vision Loss From ‘Eye Stroke’
The use of glucagon-like peptide-1 receptor agonists (GLP-1RAs), considered and effective medications for Type 2 diabetes (T2D) and weight loss, has exploded worldwide. But that doesn’t mean the drug class is completely without downsides.
The Interplay of Military Exposures, Diagnostic Delay and Precision Medicine in CRC
Care for a veteran with a new diagnosis of colorectal cancer in 2025 reflects a treatment algorithm that is more precise, more individualized, and more effective than anything available 10 years ago.
Lung Cancer Screenings Often Find Esophageal Cancer, As Well
An added benefit of lung cancer screening (LCS) at the VA is that it also often identifies incidental esophageal abnormalities.
Identification, Management of Incidental Findings in VA Lung Cancer Screening Program
Incidental findings (IFs) are common on low dose CT obtained during lung cancer screening (LCS) of veterans.
ECG-Based Devices Should Be Used to Evaluate Heart Rate Variability in Adults
In adults, pulse rate variability (PRV) and heart rate variability (HRV) aren’t interchangeable, and electrocardiography (ECG)-based devices should be used when HRV is clinically relevant and autonomic function needs to be evaluated, according to a study that addressed misinformation on wearable smart devices purchased by consumers to monitor their health.
Making Prostate Cancer Imaging More Guideline Concordant
Inappropriate imaging to stage low-risk prostate cancer is considered low-value care. A new VA study sought to determine the effectiveness of a theory-based intervention, Prostate Cancer Imaging Stewardship (PCIS), to promote guideline-concordant imaging.
Biomarker Helped Distinguish Prostate Cancer From BPH Only
Is the diagnosis benign prostatic hyperplasia (BPH) or prostate cancer (PCa)?
New Digital Measure Sheds Light on Missed Opportunities in Cancer Diagnosis
Missed and delayed cancer diagnoses can lead to devastating outcomes. A new study has taken a major step toward quantifying and addressing this issue by developing a digital quality measure to track advanced-stage cancer diagnoses—a potential signal of preventable diagnostic delays.
New Test Shows Promise for Improving Lung Cancer Detection, Reducing Costs for VA
Lung cancer is the leading cause of cancer deaths in the United States. Early detection is vital, especially for veterans, who face a disproportionately high risk of lung cancer due to higher rates of smoking and other exposures.
A Third of Type 1 Diabetes in Adults Misdiagnosed; Adult-Onset Increasing at VA, Elsewhere
A new review looked at adult-onset Type 1 diabetes and methods to improve screening and diagnosis.
AI Can Detect Hidden CVD Disease With Scans Stored in VA Patients Records
Another practical use of artificial intelligence to improve healthcare and save lives has been developed, and—not surprisingly—the VA played a key role in the effort.
PSA Screening History Useful Predictor of Prostate Cancer Risk in Seniors
In men over 70 years old, prostate-specific antigen (PSA) screening history could be a highly informative predictor of long-term risk of prostate cancer by identifying individuals with certain PSA values as very low risk, according to a recent study.
A Third of Type 1 Diabetes in Adults Misdiagnosed
A new review looked at adult-onset Type 1 diabetes and methods to improve screening and diagnosis.
Some Disparities Continue in Veterans Newly Diagnosed With T2D
Racial/ethnic disparities in glycemic control among non-Hispanic Black (NHB) and non-Hispanic white (NHW) veterans with Type 2 diabetes (T2D) have persisted, especially with very poor glycemic control, according to a new study.
Gastrointestinal Symptoms Frequently Diagnosed in Deployed Gulf War Veterans
Deployed Gulf War veterans frequently developed several gastrointestinal symptoms, including irritable bowel syndrome, dyspepsia, diarrhea, bloating and constipation, and those often persisted long after returning home, according to a new study.
Use of Non-therapeutic Laparotomy Decreased in Recent Wars but Remain Essential Battlefield Trauma-Care Tool
As combat casualty care improved over time during the wars in Iraq and Afghanistan, the use of nontherapeutic laparotomy (NTL) decreased.
Misdiagnosis of Community-Acquired Pneumonia Occurs More Than Half the Time at VA Hospitals
Pneumonia diagnoses change more often than not at VA hospitals, either because a veteran initially thought to have the infection is diagnosed with something else or because the community-acquired pneumonia diagnosis was missed when the patient entered the hospital.
Study: High-Frequency Ultrasound Better as Supplementary Tool for Tumor ID
High-frequency ultrasound (HFUS) can safely and efficiently visualize cutaneous tumor characteristics including depth, but how accurate is it?
Higher MIBC Rate but No More Mortality in Black Veterans vs. Whites
Black patients presented with the highest rates of de novo muscle-invasive bladder cancer (MIBC) at the VA, a new study has found.
Military Veterans With Sex Chromosome Aneuploidies Tend to Be Underdiagnosed
Men with sex chromosome aneuploidies, meaning they have an additional X or Y chromosome, successfully serve in the U.S. military, but they have been greatly underdiagnosed and have higher medical morbidity with aging, according to a recent study.
Many Patients with Limited Life Expectancy Choose to Undergo Lung Cancer Screening
Lung cancer screening has the potential to save lives by catching lung cancer at an early stage with definitive treatment. But it also carries potential harms—including overdiagnosis, distress from false-positive results and complications of further testing. For some people, those downsides can outweigh any benefits.
Black Veterans 50% Likelier to Get Prostate Cancer Diagnosis on First Biopsy
Black men are more likely than non-Hispanic white men to develop and die from prostate cancer, yet not much data exists that is specific to prostate-specific antigen (PSA) screening protocols by race.